Schizophrenia in Japan and cognitive behavioral therapy

Schizophrenia is one of Japan’s most common psychiatric disorders, accounting for more than half of all inpatient psychiatric beds in Japan, and also leads to a significant economic burden. Although medication (especially antipsychotic medication) is the most commonly used treatment for schizophrenia, it is recommended that psychosocial interventions such as cognitive behavioral therapy (CBT) be implemented in parallel with medication. Hence, it is imperative to promote CBT in Japan. Psychosocial interventions for schizophrenia in Japan are diverse, and there are many different places where they are practiced. This chapter reviews the current status of schizophrenia, clinical research on CBT, clinical practice of CBT and related therapies, and the future of CBT for schizophrenia in Japan.